FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1165861000168101: Gaviscon Aniseed (calcium carbonate 160 mg / 10 mL + sodium alginate 500 mg / 10 mL + sodium bicarbonate 267 mg / 10 mL) oral liquid, 100 mL, bottle (containered trade product pack)


Status: current, Defined. Date: 31-Jul 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2738451000168111 Gaviscon Aniseed (calcium carbonate 160 mg / 10 mL + sodium alginate 500 mg / 10 mL + sodium bicarbonate 267 mg / 10 mL) oral liquid, 100 mL, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2738461000168113 Gaviscon Aniseed oral liquid, 100 mL, bottle en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gaviscon Aniseed oral liquid, 100 mL, bottle Is a Gaviscon Aniseed oral liquid, 100 mL true Inferred relationship Some
Gaviscon Aniseed oral liquid, 100 mL, bottle Is a containered trade product pack true Inferred relationship Some
Gaviscon Aniseed oral liquid, 100 mL, bottle has TPUU Gaviscon Aniseed oral liquid, 10 mL true Inferred relationship Some 1
Gaviscon Aniseed oral liquid, 100 mL, bottle has container type bottle true Inferred relationship Some
Gaviscon Aniseed oral liquid, 100 mL, bottle has TP Gaviscon true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start